ArticleFuture oncology (London, England)2023

A phase II study of neoadjuvant liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in pancreatic adenocarcinoma.

Ruchi Singhal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.